Moreover, contrary to PSEBC-TSTA, PCA3-3STA remained active in androgen receptor (AR)-negative prostate cancer cells (PC-3 and DU145, Figure 1B and 2C) while it was silent in AR-positive breast cancer cells (CAMA-1, Supplemental Figure S2). This evidence concerns the gene AR and breast cancer.